STEVEN R LORANGER Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for STEVEN R LORANGER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEVEN R LORANGER. STEVEN R LORANGER is EVP and COO in TEXTRON INC ($TXT) and Director in Edwards Lifesciences Corp ($EW) and Director in Xylem Inc. ($XYL).
Latest Insider Trading Transactions of STEVEN R LORANGER
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2021 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Grant | A | 0.00 | 1,328 | 0 | 22,293 | 21 K to 22.3 K (+6.33 %) |
May 07 2021 | EW | Edwards Lifescienc ... | LORANGER STEVEN R | Director | Option Exercise | A | 91.77 | 3,270 | 300,088 | 3,270 | |
May 07 2021 | EW | Edwards Lifescienc ... | LORANGER STEVEN R | Director | Grant | A | 0.00 | 2,615 | 0 | 49,580 | 47 K to 49.6 K (+5.57 %) |
Sep 15 2020 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Sell | S | 83.95 | 18,388 | 1,543,623 | 9,098 | 27.5 K to 9.1 K (-66.90 %) |
May 14 2020 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Grant | A | 0.00 | 2,577 | 0 | 20,965 | 18.4 K to 21 K (+14.01 %) |
May 11 2020 | EW | Edwards Lifescienc ... | LORANGER STEVEN R | Director | Option Exercise | A | 217.84 | 1,378 | 300,184 | 1,378 | |
May 11 2020 | EW | Edwards Lifescienc ... | LORANGER STEVEN R | Director | Grant | A | 0.00 | 1,101 | 0 | 9,056 | 8 K to 9.1 K (+13.84 %) |
Feb 14 2020 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Sell | S | 88.61 | 30,000 | 2,658,378 | 72,443 | 102.4 K to 72.4 K (-29.28 %) |
May 17 2019 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Grant | A | 0.00 | 1,831 | 0 | 24,909 | 23.1 K to 24.9 K (+7.93 %) |
May 13 2019 | EW | Edwards Lifescienc ... | LORANGER STEVEN R | Director | Grant | A | 0.00 | 414 | 0 | 7,955 | 7.5 K to 8 K (+5.49 %) |
May 13 2019 | EW | Edwards Lifescienc ... | LORANGER STEVEN R | Director | Grant | A | 0.00 | 1,323 | 0 | 7,541 | 6.2 K to 7.5 K (+21.28 %) |
Mar 18 2019 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Sell | S | 76.99 | 10,000 | 769,917 | 120,918 | 130.9 K to 120.9 K (-7.64 %) |
May 22 2018 | EW | Edwards Lifescienc ... | LORANGER STEVEN R | Director | Option Exercise | A | 135.95 | 1,913 | 260,072 | 1,913 | |
May 22 2018 | EW | Edwards Lifescienc ... | LORANGER STEVEN R | Director | Grant | A | 0.00 | 1,655 | 0 | 6,218 | 4.6 K to 6.2 K (+36.27 %) |
May 10 2018 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Grant | A | 0.00 | 1,947 | 0 | 23,078 | 21.1 K to 23.1 K (+9.21 %) |
Dec 20 2017 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Option Exercise | M | 32.38 | 12,120 | 392,446 | 0 | |
Dec 20 2017 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Option Exercise | M | 32.38 | 5,019 | 162,515 | 12,120 | |
Dec 20 2017 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Sell | S | 68.14 | 12,120 | 825,840 | 21,131 | 33.3 K to 21.1 K (-36.45 %) |
Dec 20 2017 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Buy | M | 32.38 | 12,120 | 392,446 | 33,251 | 21.1 K to 33.3 K (+57.36 %) |
Dec 20 2017 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Sell | S | 68.00 | 5,019 | 341,314 | 21,131 | 26.2 K to 21.1 K (-19.19 %) |
Dec 20 2017 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Buy | M | 32.38 | 5,019 | 162,515 | 26,150 | 21.1 K to 26.2 K (+23.75 %) |
Dec 19 2017 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Option Exercise | M | 32.38 | 47,712 | 1,544,915 | 17,139 | |
Dec 19 2017 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Sell | S | 68.10 | 47,712 | 3,248,958 | 21,131 | 68.8 K to 21.1 K (-69.31 %) |
Dec 19 2017 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Buy | M | 32.38 | 47,712 | 1,544,915 | 68,843 | 21.1 K to 68.8 K (+225.79 %) |
Dec 15 2017 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Option Exercise | M | 32.38 | 200 | 6,476 | 64,851 | |
Dec 15 2017 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Sell | S | 68.02 | 200 | 13,604 | 21,131 | 21.3 K to 21.1 K (-0.94 %) |
Dec 15 2017 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Buy | M | 32.38 | 200 | 6,476 | 21,331 | 21.1 K to 21.3 K (+0.95 %) |
Dec 13 2017 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Option Exercise | M | 32.38 | 196 | 6,346 | 65,051 | |
Dec 13 2017 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Sell | S | 68.23 | 196 | 13,373 | 21,131 | 21.3 K to 21.1 K (-0.92 %) |
Dec 13 2017 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Buy | M | 32.38 | 196 | 6,346 | 21,327 | 21.1 K to 21.3 K (+0.93 %) |
Nov 08 2017 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Option Exercise | M | 32.38 | 50,000 | 1,619,000 | 65,247 | |
Nov 08 2017 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Sell | S | 66.25 | 37,700 | 2,497,625 | 21,131 | 58.8 K to 21.1 K (-64.08 %) |
Nov 08 2017 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Buy | M | 32.38 | 50,000 | 1,619,000 | 58,831 | 8.8 K to 58.8 K (+566.19 %) |
Jun 30 2017 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Option Exercise | M | 30.03 | 9,933 | 298,288 | 0 | |
Jun 30 2017 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Option Exercise | M | 30.03 | 56,199 | 1,687,656 | 9,933 | |
Jun 30 2017 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Sell | S | 55.05 | 9,933 | 546,802 | 8,831 | 18.8 K to 8.8 K (-52.94 %) |
Jun 30 2017 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Buy | M | 30.03 | 9,933 | 298,283 | 18,764 | 8.8 K to 18.8 K (+112.48 %) |
Jun 30 2017 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Sell | S | 55.00 | 56,199 | 3,091,057 | 8,831 | 65 K to 8.8 K (-86.42 %) |
Jun 30 2017 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Buy | M | 30.03 | 56,199 | 1,687,628 | 65,030 | 8.8 K to 65 K (+636.38 %) |
May 15 2017 | EW | Edwards Lifescienc ... | LORANGER STEVEN R | Director | Grant | A | 0.00 | 588 | 0 | 4,563 | 4 K to 4.6 K (+14.79 %) |
May 15 2017 | EW | Edwards Lifescienc ... | LORANGER STEVEN R | Director | Grant | A | 0.00 | 2,034 | 0 | 3,975 | 1.9 K to 4 K (+104.79 %) |
May 11 2017 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Grant | A | 0.00 | 2,743 | 0 | 8,831 | 6.1 K to 8.8 K (+45.06 %) |
Aug 12 2016 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Option Exercise | M | 30.03 | 28,732 | 862,822 | 66,132 | |
Aug 12 2016 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Option Exercise | M | 30.03 | 28,732 | 862,822 | 66,132 | |
Aug 12 2016 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Option Exercise | M | 30.03 | 5,155 | 154,805 | 94,864 | |
Aug 12 2016 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Option Exercise | M | 30.03 | 5,155 | 154,805 | 94,864 | |
Aug 12 2016 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Sell | S | 48.13 | 28,732 | 1,382,871 | 6,088 | 34.8 K to 6.1 K (-82.52 %) |
Aug 12 2016 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Sell | S | 48.13 | 28,732 | 1,382,871 | 6,088 | 34.8 K to 6.1 K (-82.52 %) |
Aug 12 2016 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Buy | M | 30.03 | 28,732 | 862,822 | 34,820 | 6.1 K to 34.8 K (+471.94 %) |
Aug 12 2016 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Buy | M | 30.03 | 28,732 | 862,822 | 34,820 | 6.1 K to 34.8 K (+471.94 %) |
Aug 12 2016 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Sell | S | 48.00 | 5,155 | 247,440 | 6,088 | 11.2 K to 6.1 K (-45.85 %) |
Aug 12 2016 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Sell | S | 48.00 | 5,155 | 247,440 | 6,088 | 11.2 K to 6.1 K (-45.85 %) |
Aug 12 2016 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Buy | M | 30.03 | 5,155 | 154,805 | 11,243 | 6.1 K to 11.2 K (+84.67 %) |
Aug 12 2016 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Buy | M | 30.03 | 5,155 | 154,805 | 11,243 | 6.1 K to 11.2 K (+84.67 %) |
Aug 01 2016 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Option Exercise | M | 30.03 | 32,246 | 968,347 | 100,019 | |
Aug 01 2016 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Sell | S | 48.01 | 32,246 | 1,548,130 | 6,088 | 38.3 K to 6.1 K (-84.12 %) |
Aug 01 2016 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Buy | M | 30.03 | 32,246 | 968,347 | 38,334 | 6.1 K to 38.3 K (+529.66 %) |
Jun 02 2016 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Sell | S | 44.52 | 50,000 | 2,226,000 | 77,118 | 127.1 K to 77.1 K (-39.33 %) |
May 31 2016 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Sell | S | 44.67 | 50,000 | 2,233,675 | 127,118 | 177.1 K to 127.1 K (-28.23 %) |
May 26 2016 | EW | Edwards Lifescienc ... | LORANGER STEVEN R | Director | Buy | P | 101.07 | 5,000 | 505,344 | 5,000 | 0 to 5 K |
May 17 2016 | EW | Edwards Lifescienc ... | LORANGER STEVEN R | Director | Grant | A | 0.00 | 1,941 | 0 | 1,941 | 0 to 1.9 K |
May 16 2016 | EW | Edwards Lifescienc ... | LORANGER STEVEN R | Director | Option Exercise | A | 105.59 | 6,599 | 696,788 | 6,599 | |
May 12 2016 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Grant | A | 0.00 | 2,799 | 0 | 12,588 | 9.8 K to 12.6 K (+28.59 %) |
Nov 06 2015 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Option Exercise | M | 18.63 | 100,000 | 1,863,300 | 0 | |
Nov 06 2015 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Option Exercise | M | 18.63 | 65,690 | 1,224,002 | 100,000 | |
Nov 06 2015 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Sell | S | 36.73 | 100,000 | 3,672,910 | 9,789 | 109.8 K to 9.8 K (-91.08 %) |
Nov 06 2015 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Buy | M | 18.63 | 100,000 | 1,863,300 | 109,789 | 9.8 K to 109.8 K (+1,021.55 %) |
Nov 06 2015 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Sell | S | 36.62 | 65,690 | 2,405,450 | 9,789 | 75.5 K to 9.8 K (-87.03 %) |
Nov 06 2015 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Buy | M | 18.63 | 65,690 | 1,224,002 | 75,479 | 9.8 K to 75.5 K (+671.06 %) |
May 13 2015 | XYL | Xylem Inc. | LORANGER STEVEN R | Director | Grant | A | 0.00 | 3,289 | 0 | 9,789 | 6.5 K to 9.8 K (+50.60 %) |
Mar 02 2004 | TXT | TEXTRON INC | LORANGER STEVEN R | EVP and COO | Option Exercise | A | 0.00 | 11,110 | 0 | 23,569 | |
Feb 27 2004 | TXT | TEXTRON INC | LORANGER STEVEN R | EVP and COO | Option Exercise | M | 0.00 | 20,000 | 0 | 80,000 | |
Feb 27 2004 | TXT | TEXTRON INC | LORANGER STEVEN R | EVP and COO | Sell | D | 55.66 | 20,000 | 1,113,200 | 9,700 | 29.7 K to 9.7 K (-67.34 %) |
Feb 27 2004 | TXT | TEXTRON INC | LORANGER STEVEN R | EVP and COO | Buy | M | 0.00 | 20,000 | 0 | 29,700 | 9.7 K to 29.7 K (+206.19 %) |
Feb 24 2004 | TXT | TEXTRON INC | LORANGER STEVEN R | EVP and COO | Option Exercise | A | 0.00 | 12,459 | 0 | 12,459 | |
Feb 17 2004 | TXT | TEXTRON INC | LORANGER STEVEN R | EVP and COO | Option Exercise | A | 56.43 | 29,100 | 1,642,113 | 29,100 | |
Feb 17 2004 | TXT | TEXTRON INC | LORANGER STEVEN R | EVP and COO | Grant | A | 0.00 | 9,700 | 0 | 9,700 | 0 to 9.7 K |
Page: 1